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is progressively accelerating. Well over half of all persons
in the history of the world who have ever reached the age
of 65 years are alive today.
Latest figures for the U.S. show that life expectancy for
children born in the early 1980s is 70.8 years for males and
78.2 years for females. For persons who reached the age
of 65 in 1985, an average life expectancy of 15.1 additional
years is predicted for men and 19.5 additional years for
women.
In 1985 there were 28.6 million persons aged ;::::65 years,
representing 11.9% of the U.S. population. Projections for
future demographic trends depend on varying assumptions.
"Mid-range" projections, made in 1984, indicate that in
the year 2030 there will be 34.9 million persons aged ;::::65
years, representing 21.1 % of the U.S. population or almost
double the present proportion. The fastest growing segment
of our population are those aged ;::::85 years. At present there
are approximately 2.7 million of these "oldest-old," and
they are projected to increase by nearly sixfold, reaching
almost 16 million by the year 2030.
These demographic shifts are truly dramatic and the con-
sequences to our society will be profound. Despite general
downward trends in cardiovascular mortality, by far the
leading cause of death and disability in the elderly is car-
diovascular disease, and the cardiovascular risk increases
steadily with age.
Life inevitably ends in death. As physicians, our goal
for the elderly should not be the indefinite extension of life;
for this group, the prevention of enfeeblement, disability
and dependence is the dominant health objective. As a new
recruit to the field of aging research, I look forward with
great interest to participating with you in discussion of these
important topics.
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The elderly represent the most rapidly growing group in the
nation; about 5,500 individuals reach their 65th birthday
each day. The preponderance of our elderly population is
reasonably healthy, lives independently in the community
and is adequately functional-despite a greater than 80%
prevalence of at least one chronic illness. Many elderly
persons look and feel younger than their chronologie age.
Some continue at remunerative work and most look forward
to an extended and active retirement. Thus, preventive ef-
forts are most appropriate to include in medical planning.
The elderly are, however, a highly heterogeneous group
in all respects except their chronologie age. Chronologie
age is a poor predictor of functional capability. As Pascal
stated, "Old age is just a time that is farther from the
beginning and nearer to the end."
Nevertheless, the 12% of the population >65 years of
age currently uses 30% of our national health resources.
Some 1.3 million elderly persons reside in nursing homes,
at an annual cost exceeding $13 billion. The elderly are also
disproportionately high consumers of drugs, with this 12%
of the population taking 25% of all drugs. Because drug
interactions increase logarithmically and are further accen-
tuated by the multisystem decrease in function with aging,
appropriate pharmacotherapy, in appropriate dosage, must
be prescribed with care.
Our goals for this Conference are multiple and our target
audiences varied. Many of our conclusions and recommen-
dations are designed to help physicians and other health
professionals who care for elderly patients with cardiac dis-
ease; many are designed for elderly cardiac patients them-
selves; and many are designed for society: both the general
public, including the elderly, and society's elected repre-
sentatives, the individuals who formulate and promulgate
public policy.
In a recent article in the Journalof theArnericanGeriatric
Society (1) advice was given that the physician "who vol-
untarily undertakes to deliver services to an older population
also voluntarily undertakes, explicitly or implicitly, to de-
velop and maintain a significant data base on the physical,
mental, psychologic, social, economic, legal and spiritual
realities of aging in contemporary America. "
Thus, at this Conference, to assemble a contemporary
data base on cardiovascular disease in the elderly for the
medical community, we plan to identify the features of
biologic aging that are associated with the cardiovascular
system as contrasted with those that are associated with
disease. For a number of specific cardiovascular disorders
and their manifestations we plan to define those character-
istics unique to the elderly and to provide reasonable di-
rection for the appropriate recognition and management of
specific cardiovascular illnesses. Equally important will be
delineation of the information that is yet needed to provide
quality cardiovascular care for elderly persons, information
that will likely require both basic and clinical research. So
many decisions made in the care of elderly patients are based
on data extrapolated from younger populations. We further
hope to identify those clinical features and approaches that
suggest or increase the likelihood of a favorable outcome.
But medical care does not take place in a vacuum. On
the one hand, we are the beneficiaries of unprecedented
scientific developments, with major advances made in health
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care technologies; and on the other hand, we are the recip-
ients of mandates to appropriately allocate our limited fi-
nancial resources. In this setting, the physician's obligation
to each patient remains the provision of the best (and note
that this does not necessarily mean the most) possible care-
care based on scientific knowledge, on personal skills and
on humanistic and reasonably efficient principles. A number
of questions then follow. Should age be a significant de-
terminant of the application of this high technology? What
are the appropriate biomedical and psychosocial variables
to be considered? Cost constraints often challenge our ob-
ligation to provide the best of care, particularly for elderly
patients with multisystem disease, and are likely increas-
ingly to do so; liability considerations exert a further impact.
The President's Commission on "Study of Ethical Prob-
lems in Medicine and Biomedical and Behavioral Research"
reiterated that society has an ethical obligation to ensure
equitable access to health care for all (in this case, the
elderly). This health care was delineated as including efforts
to "relieve suffering, prevent premature death, restore func-
tion, increase opportunity, provide information about the
individual's condition and provide mutual empathy and
compassion." But society's messages in the 1980s are con-
flicting ones. How can the contemporary physician fulfill
scientific, humanistic, ethical and legal standards for the
care of the elderly in the current economic climate? High
quality care for patients with serious multiple illness, a
feature characteristic of many elderly patients, is expensive.
Societal values have emphasized that cost is not to be con-
sidered a determinant, yet a multiplicity of regulations in-
creasingly addresses cost containment. What can and what
should be the resolution of this conflict?
In the structuring and planning of this 18th Bethesda
Conference, my Co-chairs Drs. Frank Marcus and Robert
O'Rourke, with the Steering Committee, helped identify
outstanding experts in a variety of subspecialty areas related
to the care of elderly patients with cardiovascular disease.
I ask each of you to accept our appreciation and our delight
that so many of you not only responded favorably, but have
already contributed considerably to the compilation and dis-
tillation of reference data for the initial scientific papers that
have been prepared for our discussions.
During the next 2 days we anticipate your further counsel
in developing consensus statements about the care of elderly
patients with cardiovascular disease-a consensus based on
scientific knowledge, on judgment, on personal compassion
and on individual and societal responsibility.
As knowledgeable professionals, scientists and citizens
we must address the bioethical dilemmas that are inherent
in the care of a burgeoning aging population in a techno-
logically oriented, but financially limited, society. Care of
the elderly-and health care of the elderly in particular-
is proving to be one of the most challenging areas of public
policy. What expectations should society, and the elderly
as a component of our society, have for health care? A
balance must be achieved between the provision of quality
care, albeit costly, when it is likely to be beneficial; the
commitment to human dignity and continuing concern for
the patient's quality of life; and fiscal responsibility, real-
izing the finite limitations to the financial and human re-
sources available for the provision of health care. Unques-
tionably the conclusions and recommendations of this
Bethesda Conference will help the American College of
Cardiology provide informed medical, social, economic and
legislative guidance-guidance designed to improve the care
of elderly patients with cardiovascular disease.
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